SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 54.74-2.1%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Spekulatius who wrote (4534)8/24/2001 2:09:35 PM
From: IRWIN JAMES FRANKEL  Read Replies (2) of 52153
 
TTP - I held back commenting in the hopes that one of the more astute contributors would do so.

Fools rush in where angels fear to tread so here goes.

The delay of iloperidone for about a year tanked the stock from a peak of 60 to 10. The stock has about $4 in cash and is burning about $1 per year.

Downside risk for the next 6 months looks like 5 to 7.

Upside over a 12 to 24 month time frame could reach 40-60. (Based solely on regaining old highs as NDA filing approaches.)

So without understanding the science (I wish I did) the risk reward looks good enough for me.

I bought recently at 10.50. Some of my friends say that it is good to buy whatever I buy after it falls 50% or you have waited 6 months. All too often they are right. :-)

As always I would welcome being corrected/instructed.

ij
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News